stockrowAxoGen, Inc.
AXGN Healthcare Medical Devices
AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.
- Revenue
- +26.2%
- EPS
- +163.2%
- Free cash flow
- +995.0%
- Total debt
- −73.1%
Quarter to September 2026, against a year earlier
Follow AXGN
Alert me
AxoGen, Inc. (AXGN) Gross margin
AxoGen, Inc.'s gross margin over the twelve months to 30 September 2026 was 74.2%, down 0.1 percentage points from fiscal 2025 (74.3%). Over the past ten years it has ranged from 74.3% (fiscal 2025) to 84.6% (fiscal 2018) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 74.3% | (1.48) |
| FY2024 | 75.8% | (0.85) |
| FY2023 | 76.6% | (1.87) |
| FY2022 | 78.5% | (3.48) |
| FY2021 | 82.0% | 1.21 |
| FY2020 | 80.8% | (2.96) |
| FY2019 | 83.7% | (0.86) |
| FY2018 | 84.6% | 0.01 |
| FY2017 | 84.6% | 0.32 |
| FY2016 | 84.3% | 2.01 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 74.8% | 2.14 |
| Jun 2026 | 72.7% | (2.49) |
| Mar 2026 | 75.2% | 1.03 |
| Dec 2025 | 74.1% | (2.42) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | 86.2% |
| AXGN AxoGen, Inc. | 74.2% |
| IRTC iRhythm Holdings, Inc. compare | 72.3% |
| ESTA Establishment Labs Holdings Inc. compare | 70.5% |
| TMDX TransMedics Group, Inc. compare | 58.6% |
| ALMR Alamar Biosciences, Inc. compare | 58.4% |
| NEOG Neogen Corporation compare | 47.4% |
| UFPT UFP Technologies, Inc. compare | 29.0% |
| ITGR Integer Holdings Corporation compare | 24.6% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on AXGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement